Twist Bioscience Corporation (TWST) Financials
TWST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 672.4 million | 226.7 million |
| March 31, 2026 | 676.2 million | 221.1 million |
| Dec. 31, 2025 | 638.1 million | 182.0 million |
| Sept. 30, 2025 | 641.9 million | 168.9 million |
TWST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -8.5 million | 18.2 million |
| March 31, 2026 | -25.5 million | 18.9 million |
| Dec. 31, 2025 | -34.8 million | 13.3 million |
| Sept. 30, 2025 | -24.2 million | 16.1 million |
TWST Net Income
No data available :(
TWST Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 166.8 million | - | 85.0 million |
| March 31, 2026 | 171.7 million | - | 95.8 million |
| Dec. 31, 2025 | 197.9 million | 85.8 million | 85.8 million |
| Sept. 30, 2025 | 232.4 million | 61.8 million | 61.8 million |
TWST Shares Outstanding
TWST Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 9.7 million | 18.0 million | 80.7 million | - |
| March 31, 2026 | 8.0 million | 19.7 million | 76.1 million | - |
| Dec. 31, 2025 | 10.0 million | 17.1 million | 69.7 million | - |
| Sept. 30, 2025 | 12.4 million | 17.0 million | 63.8 million | 7.0 million |
TWST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 118.4 million | 55.9 million |
| March 31, 2026 | 110.7 million | 53.6 million |
| Dec. 31, 2025 | 103.7 million | 49.7 million |
| Sept. 30, 2025 | 99.0 million | 48.2 million |
TWST Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TWST
Price: $124.72
52 week price:
Earnings Per Share: -2.23 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.1 million
Market Capitalization: 7.8 billion